A French advertising company that worked on Purdue Pharma’s OxyContin account agreed to pay $350 million to settle a lawsuit accusing it of falsely marketing opioids as safe and unable to be abused.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
